445 KB56 KB199820252021Furlani, BorutKouter, KatarinaRozman, DamjanaVidetič Paska, Aljaštevilka:iss. 2str. 268-278letnik:vol 68DOI:10.17344/acsi.2021.6691ISSN:1580-3155COBISSID_HOST:65405955URN:URN:NBN:SI:doc-BTRFZEI8enSlovenian Chemical SocietySlovensko kemijsko društvoActa chimica slovenicaclinical sequencinggenomicsgenomikaklinično zaporedjenucleic acidnukleinska kislinaSequencing of nucleic acids| from the first human genome to next generation sequencing in COVID-19 pandemic|Despite being around for more than 40 years, DNA sequencing is regarded as young technology in clinical medicine. As sequencing is becoming cheaper, faster and more accurate, it is rapidly being incorporated into clinical laboratories. In 2003, the completion of the first human genome opened the door to personalized medicine. Ever since it has been expected for genomics to widely impact clinical care and public health. However, many years can pass for genomic dis-coveries to reflect back and benefit the patients. DNA sequencing represents a less biased approach to diagnostics. It is not only a diagnostic tool, but can also influence clinical management and therapy. As new technologies rapidly emerge it is important for researchers and health professionals to have basic knowledge about the capabilities and drawbacks of the existing sequencing methods, and their use in clinical setting and research. This review provides an overview of nucleic acid sequencing technologies from historical perspective and later focuses on clinical utilization of sequencing. Some of the most promising areas are presented with selected examples from Slovenian researchersTEXTznanstveno časopisjejournalsSlovenian National E-content AggregatorNational and University Library of SloveniaSlovensko kemijsko društvo